Skip to content
← Full study record

NCT00003702 · BASELINE

Baseline characteristics

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia · Source last updated 2018-05-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      107
    2. group Id
      BG001
      value
      109
    3. group Id
      BG002
      value
      216
    units
    Participants
groups
  1. description
    Arm 1: Methotrexate 30 mg/m2 IM weekly
    id
    BG000
    title
    Arm 1: Methotrexate 30 mg/m2 IM Weekly
  2. description
    Arm 2: Dactinomycin 1.25 mg/m2 IV push every 2 weeks
    id
    BG001
    title
    Arm 2: Dactinomycin 1.25 mg/m2 IV Push Every 2 Weeks
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          7.9
          value
          28.8
        2. group Id
          BG001
          spread
          8.6
          value
          30.4
        3. group Id
          BG002
          spread
          8.3
          value
          29.6
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          107
        2. group Id
          BG001
          value
          109
        3. group Id
          BG002
          value
          216
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Eligible participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      107
    2. group Id
      BG001
      value
      109
    3. group Id
      BG002
      value
      216
    units
    Participants
groups
  1. description
    Arm 1: Methotrexate 30 mg/m2 IM weekly
    id
    BG000
    title
    Arm 1: Methotrexate 30 mg/m2 IM Weekly
  2. description
    Arm 2: Dactinomycin 1.25 mg/m2 IV push every 2 weeks
    id
    BG001
    title
    Arm 2: Dactinomycin 1.25 mg/m2 IV Push Every 2 Weeks
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          7.9
          value
          28.8
        2. group Id
          BG001
          spread
          8.6
          value
          30.4
        3. group Id
          BG002
          spread
          8.3
          value
          29.6
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          107
        2. group Id
          BG001
          value
          109
        3. group Id
          BG002
          value
          216
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Eligible participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice